Lightpointmedical
9 employees on LinkedIn Β· 2 known investors
Lightpoint Medical develops SENSEI, a guidance system for intracavity radio-guided surgery that uses a miniaturized single-use gamma probe to localize radioactive hotspots during minimally-invasive and robot-assisted procedures. The system is designed for surgeons treating conditions such as prostate cancer and can integrate with surgical robotic platforms.
Investors Β· 2
Non-dilutive funding Β· 1 SBIR/STTR award
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $217.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Lightpointmedical do?
- Lightpoint Medical develops SENSEI, a guidance system for intracavity radio-guided surgery that uses a miniaturized single-use gamma probe to localize radioactive hotspots during minimally-invasive and robot-assisted procedures. The system is designed for surgeons treating conditions such as prostate cancer and can integrate with surgical robotic platforms.
- Who are Lightpointmedical's investors?
- Lightpointmedical's investors include Keiretsu Forum, Venture Founders.